(æ¥å°ç®ä¼èª 28(2) 165-168, 2009.) ã»ããå½ã§ã®ç®èç§é åã§åé¢ãããMRSAã®è¬å¤æåæ§ãè¦ãã¨CLDMã¯ç±³å½ã¨æ¯ã¹æèæ´»æ§ãå£ããã¨ãããã ã»ç®èè»é¨çµç¹ææçã®æ£è
ã§MRSAãåé¢ãããå ´åã¯ãå
¥é¢å¤æ¥ãåããCA-MRSAã®å¯è½æ§ãé«ãã®ã§ãä¸çç以ä¸ã§ããã°STåå¤ãMINOãæä¸ããã ã»ãã ãSTåå¤ã¯ããå½ã§ã¯ç®èè»é¨çµç¹ææçã«ã¯ä¿éºã®é©ç¨ããªãã MRSAææçã®æ²»çã¬ã¤ãã©ã¤ã³ æ¥æ¬ææçå¦ä¼ ãããããèããã¨ã3è¬å¤ã®ä¸ã§ã¯ãã¯ããããã¤ã·ã³ã使ãããããããããªãã éçä¾ã§ã¯æMRSAè¬ï¼ãã³ã³ãã¤ã·ã³ãã¶ã¤ããã¯ã¹ããã¥ãã·ã³ï¼ã使ç¨ããã éçä¾ãå
¨èº«çç¶ãä¼´ãç®èè»é¨çµç¹ææçã§ãMRSAææçãçãããå ´åã¯ããã ã¡ã«æMRSAè¬ã®æä¸ãè¡ãã MRSAææçã®æ²»çã¬ã¤ãã©ã¤ã³ æ¥æ¬ææçå¦ä¼ å°å
ã®å ´å ãããåé¡ã«ãªãã®ã¯å°
{{#tags}}- {{label}}
{{/tags}}